JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

$2.97
-0.01 (-0.34%)
As of Sep 23, 10:50 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,379.1% upside
Low Target $31.75
Average Target $43.93
High Target $69.04
Current Price $2.97
Current
$2.97
Target
$43.93
$31.75 $43.93 avg $69.04
Scenario Analysis
Bear Case
$31.75
969.0%
Low target
Base Case
$43.93
+1,379.1%
Avg target
Bull Case
$69.04
+2,224.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$138.00
-97.8% from high
52-Week Low
$2.88
+3.1% from low
Target vs 52W High
$43.93
-68.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%